Alnylam Pharmaceuticals
ALNY
#630
Rank
A$55.53 B
Marketcap
A$415.93
Share price
0.61%
Change (1 day)
-1.75%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company